f8il10
Recombinant proteinexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2011 (NCT02076659)
Timeline
Indications
Studied for
Mechanism of action
- FibronectinINHIBITOR
FN1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- IL10
Oral
No
Parenteral
No
Topical
No
Also known as
- f8il10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07245992 | Phase 1 | Dec 31, 2025 | Philogen S.p.A. |
| NCT05622175 | Phase 1 | Mar 31, 2023 | Philogen S.p.A. |
| NCT02270632 | Phase 2 | Oct 1, 2014 | Philogen S.p.A. |
| NCT02076659 | Phase 1 | Sep 1, 2011 | Philogen S.p.A., University of Siena |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Philogen S.p.A. | For profit | 4 | 4 | 2 | 2011 |
| University of Siena | Academic/Hospital | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1